L-Serine

Supplements · Amino Acids · Supplement, Typed Supps

A building-block amino acid your body makes on its own, and an active area of research into brain and nerve health — though the exciting findings so far are mostly early-stage.

Stage by stage

Intake (Capsule or powder): Taken by mouth, or produced naturally by the body.
Small intestine (Absorbed): Absorbed alongside other amino acids, if taken orally.
Bloodstream (Circulates): Carried through the blood, including across the blood-brain barrier.
Nerve tissue (Neuroprotective research): Converted to D-serine and membrane lipids; studied for nerve-protective effects.

What the evidence supports

Serving as a building block for protein and the precursor for phosphatidylserine, sphingolipids, and the neurotransmitter-related molecule D-serine — strong evidence. Core, well-established biochemistry — serine is synthesized endogenously from a glycolytic intermediate and feeds directly into these pathways.
Supplementation improving outcomes in rare genetic conditions of impaired serine synthesis, such as certain GRIN2B-related pediatric encephalopathies or serine-synthesis-pathway disorders — limited evidence. Case reports and very small studies show improvement in specific serine-deficiency-driven conditions, but this doesn't generalize to serine-replete healthy people.
Improving cognition, mood, or slowing neurodegeneration (Alzheimer's disease, ALS) in general populations — insufficient evidence. Mechanistic and animal rationale is active and interesting, and small clinical trials are ongoing, but human trials so far are small, early-stage, or unfinished, without a confirmed clinical benefit yet.

Typical dose

Trial doses vary enormously by purpose — from roughly 1–3g/day in exploratory studies up to 15–30g/day in ALS and Alzheimer's research settings

Upper limit: No established UL; doses up to 30g/day have been tolerated in short clinical trials, though this is a research-only, medically supervised dose, not a self-directed one

Timing

With food; clinical research doses are far higher than typical supplement servings.

Time to effect

Unclear: No confirmed general time-to-effect exists; the ongoing ALS and Alzheimer’s trials run for many months and haven’t yet reported confirmed clinical benefit.

Common myth

“L-serine is a proven treatment for Alzheimer’s or ALS.” In reality: The scientific interest is real and current, and trials are ongoing, but there’s no adequately powered human trial yet confirming L-serine slows or treats Alzheimer’s or ALS. The strongest evidence is in a small number of rare, specific serine-synthesis-disorder cases, which is not the same as general neurodegeneration.

In the glossary

Absorption